$2.47
4.66% yesterday
Nasdaq, May 20, 09:48 pm CET
ISIN
US98986M1036
Symbol
ZYXI

Zynex, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
Investors can contact the law firm at no cost to learn more about recovering their losses
Neutral
PRNewsWire
one day ago
NEW YORK , May 19, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period"), of the important May 19, 2025 lead plaintiff deadline. So What: If you purchased Zynex securities during the Class Period you may be entitled to compen...
Neutral
GlobeNewsWire
3 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their Options
Neutral
Business Wire
4 days ago
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025. Zynex is a medical device manufacturer. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allega...
Neutral
PRNewsWire
6 days ago
NEW YORK , May 14, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period"), of the important May 19, 2025 lead plaintiff deadline. So What: If you purchased Zynex securities during the Class Period you may be entitled to compen...
Neutral
GlobeNewsWire
7 days ago
SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against Zynex, Inc. (NASDAQ: ZYXI), a medical device manufacturer specializing in electrotherapy devices, alleging that the company and certain of its top executives misled investors by overstating revenue through the practice of shipping excessive and unnecessary supplies to patients.
Neutral
GlobeNewsWire
7 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options
Neutral
PRNewsWire
7 days ago
LOS ANGELES , May 14, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI). IF YOU SUFFERED A LOSS ON YOUR ZYNEX INVESTMENTS, CLICK HERE BEFORE MAY 19, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What ...
Show more news

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today